M

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Watchlist Manager
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Watchlist
Price: 121.2 SAR 1.68% Market Closed
Market Cap: 2.4B SAR
Have any thoughts about
Middle East Pharmaceutical Industries Company SJSC?
Write Note

Middle East Pharmaceutical Industries Company SJSC
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Middle East Pharmaceutical Industries Company SJSC
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
M
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Cost of Revenue
-ď·Ľ131.1m
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070
Cost of Revenue
-ď·Ľ878.5m
CAGR 3-Years
-1%
CAGR 5-Years
5%
CAGR 10-Years
-3%
J
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
Cost of Revenue
-ď·Ľ397m
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Middle East Pharmaceutical Industries Company SJSC
Glance View

Market Cap
2.4B SAR
Industry
Pharmaceuticals

Middle East Pharmaceutical Industries Company SJSC is a SA-based company operating in Pharmaceuticals industry. The company is headquartered in Riyadh, Riyadh and currently employs 335 full-time employees. The company went IPO on 2024-02-27. Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The firm develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.

Intrinsic Value
88.32 SAR
Overvaluation 27%
Intrinsic Value
Price
M

See Also

What is Middle East Pharmaceutical Industries Company SJSC's Cost of Revenue?
Cost of Revenue
-131.1m SAR

Based on the financial report for Dec 31, 2023, Middle East Pharmaceutical Industries Company SJSC's Cost of Revenue amounts to -131.1m SAR.

What is Middle East Pharmaceutical Industries Company SJSC's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-2%

Over the last year, the Cost of Revenue growth was -11%. The average annual Cost of Revenue growth rates for Middle East Pharmaceutical Industries Company SJSC have been -2% over the past three years .

Back to Top